drugset / Trial / NCT05363020

S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands

NCT05363020

Phase 4 Completed 40 enrolled Dartmouth-Hitchcock Medical Center
RandomizedCrossoverTriple-blindSupportive care

Summary

The primary objective of this study is to demonstrate the feasibility of evaluating SAMe tolerability, analgesic benefits, and daily functional improvement in patients with osteoarthritis of the hands compared to placebo. The secondary objective of this study is to generate preliminary data on discomfort, function, quality of life in patients with osteoarthritis of the hands when taking SAMe compared to placebo.

Timeline

Start
2022-08-17
Primary completion
2025-04-11
Completion
2025-04-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ademetionine Unknown 400 mg Oral

Indications